ResearcherHarvard UniversityNo recent work listed
Weizheng Ren
Matched on ORCID iD 0000-0002-2825-5289; OpenAlex author ID A5046978983. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2020: 1 paper · 2021: 1 paper · 2022: 2 papers
Papers 4
- Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection. Co-author DOI 10.1177/00031348211011129↗
- Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection. Co-author DOI 10.1177/0003134821991962↗
- Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection. Co-author DOI 10.1016/j.jss.2020.07.073↗
- Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003667↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stanley W. Ashley · 4 shared papers, 2020–2022 · strength 0.88
- Paper Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreat… DOI 10.1097/sla.0000000000003667↗
- Paper Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Re… DOI 10.1177/00031348211011129↗
- Paper Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection. DOI 10.1177/0003134821991962↗
- Thomas E. Clancy · 3 shared papers, 2021–2022 · strength 0.64
- Paper Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Re… DOI 10.1177/00031348211011129↗
- Paper Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection. DOI 10.1177/0003134821991962↗
- Paper Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Trea… DOI 10.1016/j.jss.2020.07.073↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.